Cardiovascular diseases are the most frequent cause of death among persons with spinal cord injury (SCI), and these diseases are reported to occur prematurely in the disabled compared to the able bodied population. The mechanism of accelerated coronary heart disease (CHD) in persons with SCI may be partially explicable on the basis of the lipoprotein profile. We performed fasting lipoprotein determinations on 100 veterans with SCI, 50 with paraplegia and 50 with quadriplegia, and 50 veteran controls. The mean age of the subjects with SCI was 47.8 ± 1. 4 years with a duration of injury of 16.3 ± 1.2 years. The mean serum high-density lipoprotein (HDL) cholesterol was depressed in subjects with paraplegia or quadriplegia compared to controls (37 ± 1 or 40 ± 1 versus 48 ± 2 mg/dL, p < 0.0001). Although serum total cholesterol was lower (p < 0. 01) in subjects with SCI than in controls, there was no significant difference in mean serum low-density lipoprotein (LDL) cholesterol. Thirty seven p ercent of subjects with SCI have serum HDL cholesterol levels less than 35 mg/dL with no significant difference in lipoprotein distribution between high and low cord lesions. Eighteen percent of individuals with SCI have an absolute elevation of LDL cholesterol (greater than 160 mg/dL). About 40% of those with SCI and LDL cholesterol levels between 130 and 160 mg/dL also have serum HDL cholesterol values below 35 mg/dL, all of whom would have their serum HDL cholesterol level undetected if lipoprotein profiles were performed according to· present recommendations -that is, only if the serum total cholesterol is elevated. The ratio of serum total cholesterol to HDL cholesterol and serum LDH cholesterol to HDL cholesterol, commonly used ratios for risk of CHD, were calculated and are elevated in groups with SCI. In a subgroup of 12 subjects with paraplegia, a linear correlation is noted between serum HDL cholesterol values and cardiopulmonary fitness by determination of V02 max by upper body ergometry. Also, a linear correlation (p = 0. 02) is found between serum HDL cholesterol and insulin sensitivity as determined by the minimal model method.
Diseases which occur with age are being reported in persons with spinal cord injury (SCI). 1 -5 In one study2 cardiovascular dis eases were the most frequent cause of death among persons with SCI more than 30 years post injury (46% of all deaths) and among those more than 60 years of age (35% of deaths). Cardiovascular disease mortality has been reported to occur at younger ages in persons with SCI than in the nondisabled population. 2 The lipid profile determines a portion of the risk of cardiovascular disease.6-1O An increased level of activity is associated with reduced risk of CHD,l1 which may be largely due to the direct relationship between activity and high den sity lipoprotein (HDL) cholesterol. The general recommendation to perform a com-plete lipoprotein profile in individuals only if the total serum cholesterol is greater than 240 mg/dL may not be appropriate for those who are disabled, since the serum HDL cholesterol has been reported to be markedly reduced in persons with SCI. 12 -1 4 Thus, we performed a complete lipoprotein profile in 100 subjects with SCI, equally divided between those with paraplegia or quadriplegia, and compared the results to those obtained in 50 able bodied veteran controls. Since both carbohydrate metabol ism 15-19 and level of activityI2.20.21 have each individually been shown to influence the serum HDL cholesterol level, in a subset of 12 subjects with paraplegia cardiovascular fitness and peripheral insulin sensitivity were determined and compared to the level of serum HDL cholesterol.
Methods
Fasting lipoprotein determinations were performed on 50 veterans with paraplegia, 50 with quadriplegia, and 50 veteran con trols. The groups were matched for age and body mass index (BMI). Informed consent was obtained from all subjects. The serum total cholesterol and triglycerides were as sayed on SM AC (Technion Instruments) using the enzymatic method. The serum HDL cholesterol was determined by the dextran sulfate method (Technicon HDL cholesterol precipitating reagent, Technicon Instruments Corp, Tarrytown, NY) with enzymatic quantification. The serum low density lipoprotein (LDL) cholesterol was calculated from the equation: LDL choles terol = TC-(HDLc)-(TG/5), where TC is total cholesterol, HDLc is HDL cholesterol, and TG are triglycerides.
Cardiopulmonary fitness and insulin sen sitivity were determined in a subset of 12 subjects with paraplegia. Fitness was deter mined by an upper body ergometry meta bolic stress test. Determination of fitness was accompli�hed by measurement of oxy gen upt . ake (V0 2 ), carbon dioxide produc tion (VC0 2 ), minute ventilation (VE), heart rate (HR), and work (watts).22.23 A metabolic cart (system 2900, SensorMedics Corp, Y <;>rba �inda, CA) was used to measure V0 2 , VC0 2 , and VE. A heart rate telemeter (Polar Pacer, Computer Instru ments Corp) was used to measure HR. Work was measured by use of a Fleisch Universal Ergostat upper extremity ergo meter. A 12 watt incremental protocol2 4 using one minute stages was employed until the subject reached maximum effort, as determined by the following criteria: R (VC0 2 jV0 2 ) > 1.10, HR � 85% maximum predicted heart rate (MPHR = nO-age), subjective exhaustion or other limiting symptoms.
An intravenous glucose tolerance test with tolbutamide was performed according to the modified minimal-model method of Bergman25. After placement of 2 intra catheters, 4 basal samples were collected over 20 min, after which glucose (0.3 g/kg) was injected over one min. An additional injection of tolbutamide (Orinase i.v., Up john, Kalamazoo, MI) was given over 20 sec, 20 min after glucose. Subjects with BM I < 30 kg/m2 were given 300 mg tolbuta mide; subjects with BMI > 30 kg/m2 were given 500 mg. Blood samples were collected at the following times after glucose injec tion: at t = 0:2, 4, 8, 19, n, 30, 40, 50, 60, 70, 90, 120, and 180 min. The insulin sensi tivity index was calculated from the fast sampling intravenous glucose tolerance (FSIGT) test results using the program MINMOD which was run on the VAX-750 at the USC Physiology and Biophysics Department. This program accepts as input the temporal pattern of plasma insulin during the FSIGT, and must fit a simple (minimal) model of insulin-dependent glu cose utilization to the measured glucose pattern.
Diagnostic classification from a standard 75 g oral glucose tolerance test, which was administered as part of an annual physical examination, was taken from the hospital record of each subject.
All calculations and statistical analyses were performed using the ST ATVIEW soft ware program. Results are expressed as the mean value plus or minus standard error of the mean (SEM). ANOVA was used to determine the significance of differences in lipid levels among the groups. The unpaired Student's t-test was used to assess the significance of differences in lipid values between subjects with paraplegia or quad riplegia. Linear regression analyses were performed to determine the correlation between HDL cholesterol and triglycerides, cardiopulmonary fitness (V0 2 max), or insulin sensitivity (S;).
Results
The characteristics of the study and control groups are shown ( Table I ). The subjects with paraplegia and quadriplegia have a marked depression in mean serum HDL cholesterol when compared to controls (Table II) . Except for serum triglycerides, which were noted to be lower in those with quadriplegia, there is no significant differ ence in any serum lipoprotein values be tween those with paraplegia or quadriple gia. The mean serum total cholesterol is significantly lower in the subjects with SCI compared to controls, due in part to the depressed mean serum HDL cholesterol level (Table II) . The mean serum LDL cholesterol is not significantly different be tween those with paraplegia or quadriplegia or between either group with SCI and the control group. Since the ratio of total serum cholesterol to HDL cholesterol, as well as the ratio of serum LDL cholesterol to HDL cholesterol, has been found to be strongly correlated with the risk of CHD, 26,27 these ratios have been determined in our subjects (Table III) . In the group with paraplegia compared to the control group, a significant difference is noted between the ratio of total cholesterol to HDL cholesterol and the ratio of LDL cholesterol to HDL cholesterol. An addi tional significant difference is noted in the group comprising all subjects with SCI compared to the control group for the ratio of LDL cholesterol to HDL cholesterol.
An inverse correlation is noted between serum HDL cholesterol and triglyceride values in subjects with paraplegia (p < 0.0001) and quadriplegia (p < 0.005), and in controls (p < 0.005) (Fig 1) . A direct correlation is noted between the serum HDL cholesterol values and V02 max, p = 0.10. In a subgroup of 12 subjects with paraplegia, there is a significant linear cor relation (p = 0.02) between serum HDL cholesterol and insulin sensitivity (Fig 2) . Serum lipoproteins levels expressed as mean ± SEM in mg/dL. ANOV A was used to determine statistically significant changes among groups.
-p< O.OOOl, *p< O.Ol, °p< 0.05. squares), and control subjects (bottom, circles). The serum HDL cholesterol levels were divided into 3 groups: less than 30, 30-34, and levels equal to or greater than 35 mg/dL (Table IV) . There is no significant differ ence in the serum HDL cholesterol distribu tion between subjects with paraplegia and those with quadriplegia. Forty percent of subjects with paraplegia and 34% of those with quadriplegia have serum HDL choles terol levels less than 35 mg/dL.
Similarly, serum LDL cholesterol values were divided into 3 groups: less than 130, 130 to 160, and greater than 160 mg/dL (Table V) . There is no significant difference in levels of LDL cholesterol distribution between subjects with paraplegia and those with quadriplegia. Eighteen percent of indi- vi duals with SCI have an absolute elevation of LDL cholesterol, ie greater than 160 mg/dL; 7 of these 18 subjects also have a serum HDL cholesterol less than 35 mg/dL, thus having 2 independent risk factors of CHD. Of the 26 subjects with SCI and serum LDL cholesterol values between 130 and 160 mg/dL, 11 have depressed serum HDL cholesterol levels, thus having one relative and one absolute risk factor of CHD. The serum lipoprotein profile was divided by the carbohydrate tolerance of the sub jects with SCI (Table VI) . No significant difference in lipoprotein profile is demon strated between groups with normal, im paired or diabetic oral glucose tolerance.
Discussion
Several reports have revealed lower HD L cholesterol levels in persons with SCI. 1 2 -1 4 The Framingham Study6,7 and other epide miological studies 1 11, 11 have reported an in verse relationship between the HDL choles terol level and CHD. In this report, we noted a depressed mean serum HDL choles terol level in subjects with paraplegia and quadriplegia compared to mean values in able bodied controls. Almost 40% of the subjects with SCI had serum HDL choles terol levels below 35 mg/dL, an independent risk factor of CHD. In the subjects with SCI and in the controls, strong inverse correla tions were demonstrated between serum triglycerides and HDL cholesterol. This inverse relationship may reflect the effects of plasma insulin, elevated as a consequence of reduced peripheral insulin sensitivity, on lipid metabolism. Hyperinsulinemia may cause increased hepatic triglyceride produc tion, 1 9 which, in turn, tends to lower serum HDL cholesterol, perhaps by enhancing clearance mechanisms. 16 Brenes et al 1 3 reported that in relatively young and inactive men with SCI the mean serum HDL cholesterol level was de pressed, whereas in highly trained wheel chair athletes the mean value for serum HDL cholesterol was closer to normal levels. No significant difference was noted between mean serum HDL cholesterol levels in inactive subjects with paraplegia or quadriplegia. 1 3 Dearwater et al 1 4 noted that in untrained men with SCI, the mean serum HDL cholesterol level was depressed com pared to the mean value in wheelchair athletes. In a small number of subjects Hooker and Wells28 addressed the effects of low intensity and moderate intensity wheel chair ergometry exercise on lipids. Only in the moderate intensity exercise group was a significant increase in serum mean HDL cholesterol level demonstrated. It should be noted, however, that the mean serum HDL cholesterol value before exercise training in the low intensity group was higher than the mean value after exercise training in the moderate exercise group.
There are additional lipoprotein measure ments or mathematical expressions that have been associated with risk of CHD. In a recent study, 26 the ratio of serum total cholesterol to HDL cholesterol was a par ticularly strong discriminator of risk of myocardial infarction. An increase of one unit was associated with a mean increase of 53% in the risk of myocardial infarction. 26 Subjects with paraplegia in our report had about a one unit increment in this ratio compared with the control group. The inverse relationship between serum HDL cholesterol and risk of myocardial infarction appeared stronger for men with lower levels of total cholesterol,26 such as those with SCI in this report. This ratio was a stronger predictor of risk than was total cholesterol, total HDL cholesterol, subfractions of HDL cholesterol, or levels of apolipoproteins. 26 The ratio of LDL cholesterol to HDL cholesterol may be a better indicator of risk of CHD in individuals with SCI since a depressed HDL cholesterol lowers total cholesterol but does not affect LDL choles terol. Hence, the additional significant dif ference between the control group and the subjects with SCI was present when this latter ratio was used rather than the ratio of total cholesterol to HDL cholesterol. Other measurements, such as alipoprotein B-lOO (the main apoprotein in the LD L particle) and alipoprotein A-I (one of the apo proteins in the HDL particle), as well as other lipid and/or apoprotein ratios (B-100 to HDL cholesterol or B-lOO to A-I), may also be significant predictors of risk of CHD in the person with SCI. A properly con trolled, long term prospective study of CHD morbidity and mortality in relationship to lipoprotein and apoprotein values in perReferences sons with SCI will provide us with this information.
